Fig. 1From: A phase 1, first-in-human study of 18F-GP1 positron emission tomography for imaging acute arterial thrombosis18F-GP1 biodistribution over time. The 18F-GP1 uptake in the kidney, spleen and blood gradually decreases over time. The 18F-GP1 uptake in AAT lesions remains constant from 7Â min after injection. The median values of ten patients are shownBack to article page